Aehr Test Systems (NASDAQ: AEHR) is a Technology company (Semiconductors) with a market capitalization of $1.7B. The Maz Rating grades it against the other companies in its sector.
About three months ago (July 2, 2026), Aehr Test Systems had a Maz Rating of 3.04 out of 5 (B+, Buy), ranked against the other companies in its sector. Its strongest factor then was Momentum (4.91), among the strongest in its sector; its weakest was Valuation (1.04), among the most expensive in its sector. The other factors: Financial Health 3.90 (above most of its sector); Profitability 1.95 (below most of its sector); Growth 1.53 (below most of its sector). The current rating is for members: log in to see it.
At $53.57, Aehr Test Systems trades at 824.8x trailing earnings, 22.0x sales and 7.2x book value, with an EV/EBITDA of 702.0. Over the last twelve months it generated about $79M of revenue and $2M of net income. It runs a gross margin of 40.6%, an operating margin of -5.5% and a net margin of 2.9%. It shows return on equity of 1.2%, return on invested capital of 1.9% and a free cash flow yield of -0.4%. On the balance sheet: a debt-to-equity ratio of 0.04 and a current ratio of 7.15. Over the past 52 weeks the share price ranged from $18.70 to $147.40, with a beta of 3.37.
Aehr Test Systems does not currently pay a dividend.
5 Wall Street analyst ratings cover the stock: 3 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.